Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SeaStar Medical Holding (ICU) Change in Accured Expenses (2023 - 2025)

Historic Change in Accured Expenses for SeaStar Medical Holding (ICU) over the last 3 years, with Q3 2025 value amounting to $164000.0.

  • SeaStar Medical Holding's Change in Accured Expenses fell 3251.03% to $164000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$198000.0, marking a year-over-year decrease of 12636.48%. This contributed to the annual value of $1.9 million for FY2024, which is 26266.92% up from last year.
  • Latest data reveals that SeaStar Medical Holding reported Change in Accured Expenses of $164000.0 as of Q3 2025, which was down 3251.03% from -$1.4 million recorded in Q2 2025.
  • SeaStar Medical Holding's 5-year Change in Accured Expenses high stood at $943000.0 for Q4 2024, and its period low was -$1.4 million during Q2 2025.
  • In the last 3 years, SeaStar Medical Holding's Change in Accured Expenses had a median value of $164000.0 in 2025 and averaged $113727.3.
  • In the last 5 years, SeaStar Medical Holding's Change in Accured Expenses soared by 62099.45% in 2024 and then tumbled by 30538.92% in 2025.
  • Over the past 3 years, SeaStar Medical Holding's Change in Accured Expenses (Quarter) stood at -$181000.0 in 2023, then skyrocketed by 620.99% to $943000.0 in 2024, then tumbled by 82.61% to $164000.0 in 2025.
  • Its Change in Accured Expenses was $164000.0 in Q3 2025, compared to -$1.4 million in Q2 2025 and $67000.0 in Q1 2025.